MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10157-016-1271-y

Медицинская библиотека · Clinical and experimental nephrology · 2016

Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.

Ozawa Masatoyo, Komatsuda Atsushi, Ohtani Hiroshi, Nara Mizuho, Sato Ryuta, Togashi Masaru, Takahashi Naoto, Wakui Hideki

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Few studies have been conducted on the long-term prognosis of patients with amyloid light chain (AL) and amyloid A (AA) renal amyloidosis in the same cohort.

METHODS

We retrospectively examined 68 patients with biopsy-proven renal amyloidosis (38 AL and 30 AA). Clinicopathological findings at the diagnosis and follow-up data were evaluated in each patient. We analyzed the relationship between clinicopathological parameters and survival data.

RESULTS

Significant differences were observed in several clinicopathological features, such as proteinuria levels, between the AL and AA groups. Among all patients, 84.2 % of the AL group and 93.3 % of the AA group received treatments for the underlying diseases of amyloidosis. During the follow-up period (median 18 months in AL and 61 months in AA), 36.8 % of the AL group and 36.7 % of the AA group developed end-stage renal failure requiring dialysis, while 71.1 % of the AL group and 56.7 % of the AA group died. Patient and renal survivals were significantly longer in the AA group than in the AL group. eGFR of >60 mL/min/1.73 m2 at biopsy and an early histological stage of glomerular amyloid deposition were identified as low-risk factors. A multivariate analysis showed that cardiac amyloidosis and steroid therapy significantly influenced patient and renal survivals.

CONCLUSIONS

Our results showed that heart involvement was the major predictor of poor outcomes in renal amyloidosis, and that the prognosis of AA renal amyloidosis was markedly better than that in previously reported cohorts. Therapeutic advances in inflammatory diseases are expected to improve the prognosis of AA amyloidosis.

Для цитирования: Ozawa Masatoyo, Komatsuda Atsushi, Ohtani Hiroshi, Nara Mizuho, Sato Ryuta, Togashi Masaru, Takahashi Naoto, Wakui Hideki. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.. Clinical and experimental nephrology. 2016. DOI: 10.1007/s10157-016-1271-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.